Vladimir Cejka

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

William G. Herrington, Christoph Wanner, Parminder K. Judge et al. · Nephrology Dialysis Transplantation · 2022 · 108 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study

Caroline Morbach, Floran Sahiti, Theresa Tiffe et al. · PLoS ONE · 2020 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study

Caroline Morbach, Götz Gelbrich, Theresa Tiffe et al. · European Journal of Preventive Cardiology · 2020 · 46 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12